https://www.pharmaglobenewswire.com/essential-thrombocythemia-market-set-for-significant-growth-driven-by-emerging-therapies-rising-prevalence-and-expanding-pipeline-through-2036/ 2026-05-14T09:45:23+00:00 https://www.pharmaglobenewswire.com/ai-in-medical-diagnostics-market/ 2026-05-13T19:10:29+00:00 https://www.pharmaglobenewswire.com/niemann-pick-disease-market/ 2026-05-13T18:47:29+00:00 https://www.pharmaglobenewswire.com/bipolar-depression-market-poised-for-robust-growth-with-upcoming-novel-therapies-and-improved-diagnostics-delveinsight/ 2026-05-13T09:48:13+00:00 https://www.pharmaglobenewswire.com/osteosarcoma-market-set-to-witness-significant-growth/ 2026-05-13T09:41:37+00:00 https://www.pharmaglobenewswire.com/delveinsights-chronic-pain-market-report-reveals-strong-growth-potential-across-the-us-europe-and-japan-by-2034/ 2026-05-13T08:38:46+00:00 https://www.pharmaglobenewswire.com/myelofibrosis-market-set-to-reach-usd-5-6-billion-by-2034-across-7mm-healthcare-economies/ 2026-05-13T05:17:56+00:00 https://www.pharmaglobenewswire.com/medical-marijuana-therapeutics-market-set-for-significant-expansion-across-the-7mm/ 2026-05-12T06:34:43+00:00 https://www.pharmaglobenewswire.com/graft-versus-host-disease-market-set-to-surpass-usd-2-1-billion-in-2025-driven-by-emerging-therapies-and-rising-hsct-procedures-across-seven-major-markets/ 2026-05-12T04:47:57+00:00 https://www.pharmaglobenewswire.com/hidradenitis-suppurativa-market/ 2026-05-11T17:32:02+00:00 https://www.pharmaglobenewswire.com/prefilled-syringes-market-insights-market-trends-and-market-forecast-2032/ 2026-05-11T11:23:04+00:00 https://www.pharmaglobenewswire.com/polycythemia-vera-market-size-share-growth-trends-therapies-and-emerging-pipeline-outlook-2026-2036/ 2026-05-11T05:07:44+00:00 https://www.pharmaglobenewswire.com/dravet-syndrome-market-insights-epidemiology-and-market-forecast-2036/ 2026-05-08T13:17:56+00:00 https://www.pharmaglobenewswire.com/non-small-cell-lung-cancer-market-set-to-surpass-usd-33-billion-driven-by-breakthrough-therapies-pipeline-innovation-and-rising-global-incidence-through-2036/ 2026-05-08T10:22:10+00:00 https://www.pharmaglobenewswire.com/protac-market-forecast-signals-robust-growth-through-2034/ 2026-05-07T17:44:09+00:00 https://www.pharmaglobenewswire.com/orforglipron-market-set-for-significant-expansion-through-2034/ 2026-05-07T17:22:01+00:00 https://www.pharmaglobenewswire.com/iga-nephropathy-market-comprehensive-epidemiology-analysis-and-forecast-through-2034/ 2026-05-07T11:34:24+00:00 https://www.pharmaglobenewswire.com/kidney-transplant-rejection-market-set-to-reach-usd-6647-million-by-2034-driven-by-innovative-therapies-and-rising-transplant-rates-globally/ 2026-05-07T10:39:32+00:00 https://www.pharmaglobenewswire.com/the-postpartum-depression-treatment-market-size-7mm-was-estimated-to-be-usd-260-million-in-2023-and-it-is-projected-to-grow-by-2036-estimates-delveinsight/ 2026-05-06T10:22:07+00:00 https://www.pharmaglobenewswire.com/bipolar-disorder-market-size-in-the-7mm-is-projected-to-grow-at-a-significant-cagr-by-2036-estimates-delveinsight/ 2026-05-06T10:06:56+00:00 https://www.pharmaglobenewswire.com/advanced-renal-cell-carcinoma-pipeline-insight-2026/ 2026-05-06T09:25:26+00:00 https://www.pharmaglobenewswire.com/preeclampsia-market-expected-to-grow-from-usd-87-million-in-2025-to-usd-116-million-by-2036-driven-by-emerging-therapeutics-and-rising-global-incidence/ 2026-05-06T07:03:21+00:00 https://www.pharmaglobenewswire.com/acute-kidney-injury-market-insights-epidemiology-and-market-forecast-2036/ 2026-05-05T10:56:20+00:00 https://www.pharmaglobenewswire.com/multiple-system-atrophy-market-global-epidemiology-emerging-therapies-pipeline-analysis-and-commercial-forecast-across-the-7-major-markets-through-2036/ 2026-05-05T06:50:41+00:00 https://www.pharmaglobenewswire.com/ventricular-assist-devices-market/ 2026-05-04T14:59:28+00:00 https://www.pharmaglobenewswire.com/spinal-cord-injury-market-set-to-surpass-usd-350-million-driven-by-emerging-neuroprotective-and-regenerative-therapies-across-seven-major-markets/ 2026-05-04T11:32:16+00:00 https://www.pharmaglobenewswire.com/achondroplasia-market-insights-epidemiology-and-market-forecast-2036/ 2026-05-04T07:02:58+00:00 https://www.pharmaglobenewswire.com/preeclampsia-market-insights-epidemiology-and-market-forecast-2036/ 2026-05-01T06:59:15+00:00 https://www.pharmaglobenewswire.com/interleukin-2-il-2-market-global-trends-epidemiology-drug-pipeline-and-forecast-analysis-through-2034/ 2026-05-01T05:42:54+00:00 https://www.pharmaglobenewswire.com/bacterial-vaginosis-market-insights-epidemiology-and-market-forecast-2034/ 2026-04-30T10:01:33+00:00 https://www.pharmaglobenewswire.com/cardiac-monitoring-devices-market-to-reach-usd-31-6-billion-by-2032/ 2026-04-30T09:57:52+00:00 https://www.pharmaglobenewswire.com/thymidine-kinase-2-deficiency-market-set-for-explosive-growth-fda-approval-of-kygevvi-sparks-a-new-era-of-targeted-mitochondrial-disease-therapies-through-2034/ 2026-04-29T06:47:12+00:00 https://www.pharmaglobenewswire.com/dermatomyositis-market-set-to-advance-with-improved-diagnosis-and-emerging-immunotherapies-by-2034-says-delveinsight/ 2026-04-29T06:31:47+00:00 https://www.pharmaglobenewswire.com/cocaine-use-disorder-pipeline-appears-robust-with-12-key-pharma-companies-actively-working-in-the-therapeutics-segment-delveinsight/ 2026-04-29T06:14:20+00:00 https://www.pharmaglobenewswire.com/chronic-spontaneous-urticaria-market-size-in-the-7mm-was-usd-2000-million-in-2023-is-expected-to-grow-a-significant-cagr-by-2034-estimates-delveinsight/ 2026-04-29T06:06:54+00:00 https://www.pharmaglobenewswire.com/electrosurgical-devices-market/ 2026-04-29T05:56:24+00:00 https://www.pharmaglobenewswire.com/complement-3-glomerulopathy-c3g-market-size/ 2026-04-29T05:54:45+00:00 https://www.pharmaglobenewswire.com/postoperative-acute-pain-market-insights-epidemiology-and-market-forecast-2034/ 2026-04-29T05:46:06+00:00 https://www.pharmaglobenewswire.com/non-alcoholic-steatohepatitis-nash-market-insights-epidemiology-and-market-forecast-2032/ 2026-04-28T16:30:48+00:00 https://www.pharmaglobenewswire.com/food-allergy-drugs-market-2034/ 2026-04-28T09:19:39+00:00 https://www.pharmaglobenewswire.com/systemic-scleroderma-market-insights-epidemiology-and-market-forecast-2034/ 2026-04-27T07:31:06+00:00 https://www.pharmaglobenewswire.com/regulatory-t-cells-tregs-market-set-to-witness-significant-growth-driven-by-autoimmune-oncology-and-neurodegenerative-disease-advancements-through-2034/ 2026-04-27T05:57:14+00:00 https://www.pharmaglobenewswire.com/endometrial-cancer-market-insights-epidemiology-and-market-forecast-2034/ 2026-04-24T11:26:40+00:00 https://www.pharmaglobenewswire.com/travelers-diarrhea-market-insights-epidemiology-and-market-forecast-2034/ 2026-04-24T11:17:53+00:00 https://www.pharmaglobenewswire.com/substance-use-disorder-market-insights-epidemiology-and-market-forecast-2034/ 2026-04-24T11:12:53+00:00 https://www.pharmaglobenewswire.com/iga-nephropathy-market-set-to-surpass-usd-1-5-billion-in-2025-amid-rising-disease-awareness-novel-therapies-and-expanding-treatment-landscape-across-seven-major-markets/ 2026-04-24T10:09:55+00:00 https://www.pharmaglobenewswire.com/thyroid-eye-disease-pipeline-accelerates-with-20-companies-advancing-innovative-therapies-across-clinical-stages/ 2026-04-23T17:37:51+00:00 https://www.pharmaglobenewswire.com/acute-myocardial-infarction-market-set-to-surge-from-usd-1630-million-in-2025-to-usd-5392-million-by-2034-driven-by-innovative-therapies-and-rising-cardiovascular-disease-burden/ 2026-04-23T11:14:17+00:00 https://www.pharmaglobenewswire.com/general-surgery-devices-market-size-to-surpass-usd-35-4-billion-by-2032/ 2026-04-22T09:08:50+00:00 https://www.pharmaglobenewswire.com/immune-thrombocytopenic-purpura-market-poised-for-significant-growth-driven-by-novel-therapies-expanding-pipeline-and-rising-global-disease-burden-through-2034/ 2026-04-22T07:29:12+00:00 https://www.pharmaglobenewswire.com/celiac-disease-pipeline-advances-as-25-companies-progress-30-therapies-across-clinical-trials/ 2026-04-21T07:03:04+00:00 https://www.pharmaglobenewswire.com/obesity-market-insights-epidemiology-and-market-forecast-2034/ 2026-04-21T06:30:14+00:00 https://www.pharmaglobenewswire.com/ewing-sarcoma-market-set-to-expand-significantly-amid-rising-pipeline-activity-novel-therapies-and-growing-unmet-clinical-needs-globally/ 2026-04-21T05:48:51+00:00 https://www.pharmaglobenewswire.com/polycythemia-vera-market-insights-epidemiology-and-market-forecast-2036/ 2026-04-20T14:00:39+00:00 https://www.pharmaglobenewswire.com/melanoma-clinical-trial-analysis/ 2026-04-20T12:59:48+00:00 https://www.pharmaglobenewswire.com/medical-device-contract-manufacturing-global-market/ 2026-04-20T12:48:48+00:00 https://www.pharmaglobenewswire.com/metastatic-conventional-chondrosarcoma-therapeutics-market-size-in-the-7mm-is-projected-to-grow-at-a-significant-cagr-by-2034-estimates-delveinsight/ 2026-04-20T11:56:57+00:00 https://www.pharmaglobenewswire.com/the-global-stress-urinary-incontinence-devices-market-size-is-growing-at-a-cagr-of-6-53-by-2034-estimates-delveinsight/ 2026-04-20T11:16:30+00:00 https://www.pharmaglobenewswire.com/irritable-bowel-syndrome-market-set-for-significant-growth-driven-by-emerging-therapies-rising-disease-prevalence-and-expanding-treatment-options-across-the-7mm/ 2026-04-20T06:57:17+00:00 https://www.pharmaglobenewswire.com/knee-osteoarthritis-market-insights-epidemiology-and-market-forecast-2034/ 2026-04-17T11:48:18+00:00 https://www.pharmaglobenewswire.com/sarcopenia-market-to-grow-from-usd-2276-million-in-2025-to-usd-5626-million-in-2034-delveinsight/ 2026-04-17T11:29:54+00:00 https://www.pharmaglobenewswire.com/non-postoperative-acute-pain-market-size-valued-at-usd-3600-million-in-2023-delveinsight/ 2026-04-17T11:01:09+00:00 https://www.pharmaglobenewswire.com/traumatic-brain-injury-market-projected-to-reach-usd-30-billion-in-2024-growing-at-10-9-cagr-through-2034/ 2026-04-17T10:36:28+00:00 https://www.pharmaglobenewswire.com/systemic-sclerosis-market-projected-to-reach-usd-2660-million-by-2034/ 2026-04-17T09:58:19+00:00 https://www.pharmaglobenewswire.com/igg4-related-disease-market-set-to-surge-at-34-60-cagr-reaching-new-heights-by-2034-driven-by-emerging-therapies-and-rising-disease-awareness-globally/ 2026-04-17T09:06:54+00:00 https://www.pharmaglobenewswire.com/inflammatory-myositis-market-set-for-remarkable-growth-projected-cagr-of-11-7-through-2034-driven-by-emerging-therapies-and-rising-patient-demand-across-seven-major-markets/ 2026-04-16T05:50:26+00:00 https://www.pharmaglobenewswire.com/chronic-spontaneous-urticaria-market-set-to-surpass-usd-2000-million-by-2025-driven-by-emerging-biologics-rising-disease-awareness-and-expanding-global-treatment-access/ 2026-04-16T05:49:26+00:00 https://www.pharmaglobenewswire.com/whim-syndrome-market-epidemiology-insights-emerging-therapies-pipeline-analysis-and-growth-forecast-across-the-7-major-markets-through-2034/ 2026-04-14T12:22:08+00:00 https://www.pharmaglobenewswire.com/allergic-rhinitis-market-set-to-surge-beyond-usd-3600-million-as-emerging-therapies-and-rising-global-prevalence-drive-substantial-growth-through-2034/ 2026-04-13T11:02:37+00:00 https://www.pharmaglobenewswire.com/liver-cirrhosis-market-size-share-trends-emerging-therapies-epidemiology-and-forecast-2024-2034/ 2026-04-12T14:39:26+00:00 https://www.pharmaglobenewswire.com/multiple-myeloma-comprehensive-market-intelligence-epidemiology-and-forecast-analysis-through-2034/ 2026-04-10T06:41:00+00:00 https://www.pharmaglobenewswire.com/eczema-pipeline-2026-outlook-100-clinical-assets-and-3-key-late-stage-candidates-to-watch/ 2026-04-09T15:45:20+00:00 https://www.pharmaglobenewswire.com/lassa-fever-clinical-trials-2025-ema-pdma-fda-approvals-medication-therapies-treatment-market-moa-roa-and-companies-by-delveinsight/ 2026-04-09T15:13:45+00:00 https://www.pharmaglobenewswire.com/acute-myeloid-leukemia-clinical-trial-pipeline-appears-robust-with-100-key-pharma-companies-actively-working-in-the-domain/ 2026-04-09T14:44:23+00:00 https://www.pharmaglobenewswire.com/wp-content/uploads/2026/04/acute-myeloid-leukemia-pipeline.jpg https://www.pharmaglobenewswire.com/migraine-clinical-trial-analysis/ 2026-04-09T13:52:22+00:00 https://www.pharmaglobenewswire.com/wp-content/uploads/2026/04/migraine-pipeline.jpg https://www.pharmaglobenewswire.com/groundbreaking-growth-in-esophageal-cancer-market-forecast-through-2034-driven-by-innovation-diagnosis-and-therapeutic-advances-worldwide/ 2026-04-09T09:28:47+00:00 https://www.pharmaglobenewswire.com/sickle-cell-disease-treatment-pipeline-detailed-2026-insights/ 2026-04-08T12:39:09+00:00 https://www.pharmaglobenewswire.com/alzheimers-disease-market-insight-epidemiology-and-market-forecast-2034/ 2026-04-08T12:32:30+00:00 https://www.pharmaglobenewswire.com/kras-inhibitors-market-poised-for-explosive-growth-projected-to-surge-from-usd-526-million-in-2025-to-usd-7847-million-by-2034/ 2026-04-08T11:59:26+00:00 https://www.pharmaglobenewswire.com/heparin-induced-thrombocytopenia-market-analysis-epidemiology-forecast-and-treatment-landscape-through-2032/ 2026-04-08T11:43:20+00:00 https://www.pharmaglobenewswire.com/congenital-adrenal-hyperplasia-drugs-market-2034-emerging-therapies-clinical-trials-and-key-players/ 2026-04-08T11:04:03+00:00 https://www.pharmaglobenewswire.com/wp-content/uploads/2026/04/Untitled-design-3.png https://www.pharmaglobenewswire.com/alopecia-areata-market-emerging-therapies-epidemiology-and-growth-forecast-2026-2036-across-seven-major-markets/ 2026-04-07T16:51:59+00:00 https://www.pharmaglobenewswire.com/sglt2-inhibitor-market-size-in-the-7mm-is-projected-to-grow-at-a-significant-cagr-by-2034-estimates-delveinsight/ 2026-04-07T11:38:34+00:00 https://www.pharmaglobenewswire.com/clk-inhibitors-market-size-in-the-7mm-is-projected-to-grow-at-a-significant-cagr-by-2034-estimates-delveinsight/ 2026-04-07T11:27:33+00:00 https://www.pharmaglobenewswire.com/hepatic-cirrhosis-comprehensive-market-intelligence-epidemiology-and-forecast-analysis-through-2032/ 2026-04-07T11:05:42+00:00 https://www.pharmaglobenewswire.com/acute-kidney-injury-market-epidemiology-therapies-companies-delveinsight/ 2026-04-06T10:57:06+00:00 https://www.pharmaglobenewswire.com/spondylolisthesis-market-poised-for-significant-growth-driven-by-advanced-spinal-therapies-rising-disease-burden-and-expanding-surgical-innovation-across-seven-major-countries/ 2026-04-06T08:13:26+00:00 https://www.pharmaglobenewswire.com/celiac-disease-clinical-trial-pipeline-gains-momentum-20-companies-lead-the-charge-in-pioneering-new-treatments-delveinsight/ 2026-04-01T12:07:55+00:00 https://www.pharmaglobenewswire.com/spinocerebellar-ataxias-market-emerging-therapies-epidemiological-trends-and-pipeline-innovations-reshaping-neurological-care/ 2026-04-01T09:42:02+00:00 https://www.pharmaglobenewswire.com/soft-tissue-sarcoma-with-lung-metastases-market-epidemiology-emerging-therapies-pipeline-analysis-and-forecast-through-2036/ 2026-04-01T09:40:41+00:00 https://www.pharmaglobenewswire.com/soft-tissue-defect-market-growth-trends-epidemiology-treatment-innovations-and-competitive-landscape-through-2034/ 2026-04-01T09:39:37+00:00 https://www.pharmaglobenewswire.com/smoking-cessation-and-nicotine-addiction-market-comprehensive-analysis-of-epidemiology-emerging-therapies-and-growth-opportunities-across-seven-major-markets-through-2034/ 2026-04-01T09:36:56+00:00 https://www.pharmaglobenewswire.com/eczema-clinical-trial-pipeline-accelerates-as-100-pharma-companies-rigorously-develop-drugs-for-market-entry-delveinsight/ 2026-03-30T11:53:06+00:00 https://www.pharmaglobenewswire.com/wp-content/uploads/2026/03/Gemini_Generated_Image_968faw968faw968f.png https://www.pharmaglobenewswire.com/global-strategic-preparedness-drives-growth-in-smallpox-market-amid-advancements-in-vaccines-antivirals-and-biodefense-initiatives/ 2026-03-27T19:03:11+00:00 https://www.pharmaglobenewswire.com/advancing-therapeutic-innovations-and-expanding-clinical-insights-drive-growth-in-inflammatory-pain-market-landscape/ 2026-03-26T04:32:31+00:00 https://www.pharmaglobenewswire.com/advancing-clinical-innovation-and-market-expansion-in-pleural-effusion-therapeutics-across-global-healthcare-systems/ 2026-03-25T18:48:11+00:00 https://www.pharmaglobenewswire.com/geographic-atrophy-market-poised-for-robust-growth-2025-2034-driven-by-expanding-complement-inhibitor-adoption-delveinsight/ 2026-03-25T07:25:09+00:00 https://www.pharmaglobenewswire.com/wp-content/uploads/2026/03/Gemini_Generated_Image_wx3auwx3auwx3auw.png https://www.pharmaglobenewswire.com/pigment-epithelial-detachment-market-expected-to-experience-substantial-expansion-across-7mm-propelled-by-growing-elderly-demographics-and-cutting-edge-treatments-delveinsight/ 2026-03-25T07:17:30+00:00 https://www.pharmaglobenewswire.com/peptic-ulcers-market-insights-epidemiology-and-forecast-through-2032-comprehensive-analysis-by-delveinsight/ 2026-03-25T06:59:27+00:00 https://www.pharmaglobenewswire.com/tourette-syndrome-pipeline-2026-investigational-therapies-clinical-trial-advances-and-key-regulatory-developments-by-delveinsight/ 2026-03-25T06:48:15+00:00 https://www.pharmaglobenewswire.com/tay-sachs-disease-pipeline-2026-emerging-therapies-clinical-trial-progress-and-key-developmental-milestones-by-delveinsight/ 2026-03-25T06:47:02+00:00 https://www.pharmaglobenewswire.com/polycystic-ovarian-syndrome-pcos-pipeline-2026-emerging-treatments-clinical-trial-progress-and-regulatory-updates-by-delveinsight/ 2026-03-25T06:22:13+00:00 https://www.pharmaglobenewswire.com/comprehensive-insights-into-advancing-therapies-epidemiology-trends-and-future-growth-of-myeloproliferative-neoplasms-market-landscape/ 2026-03-24T18:53:10+00:00 https://www.pharmaglobenewswire.com/menin-inhibitor-market-size-in-the-7mm-is-projected-to-grow-at-a-significant-cagr-by-2034-estimates-delveinsight/ 2026-03-24T13:40:28+00:00 https://www.pharmaglobenewswire.com/house-dust-mite-allergy-market-outlook-highlights-growth-drivers-innovations-and-treatment-advancements-worldwide/ 2026-03-23T19:32:14+00:00 https://www.pharmaglobenewswire.com/coronary-microvascular-dysfunction-market-size-in-the-7mm-is-expected-to-grow-at-a-significant-cagr-by-2034-estimates-delveinsight/ 2026-03-20T15:33:59+00:00 https://www.pharmaglobenewswire.com/nonalcoholic-steatohepatitis-market-size-7mm-was-usd-2114-million-in-2023-and-is-projected-to-increase-at-a-significant-cagr-by-2034-estimates-delveinsight/ 2026-03-20T14:55:49+00:00 https://www.pharmaglobenewswire.com/expanding-therapeutic-horizons-and-strategic-innovations-shape-the-future-of-asperger-syndrome-treatment-market/ 2026-03-20T14:52:25+00:00 https://www.pharmaglobenewswire.com/somatotropin-deficiency-market-outlook-expands-with-advancements-in-hormone-therapies-and-diagnostics/ 2026-03-20T14:51:12+00:00 https://www.pharmaglobenewswire.com/plaque-psoriasis-market-outlook-2026-2034-driven-by-innovation-biologics-and-rising-disease-burden/ 2026-03-20T14:49:46+00:00 https://www.pharmaglobenewswire.com/venous-thromboembolism-market-expands-rapidly-with-advancements-in-diagnostics-therapeutics-and-epidemiological-insights-driving-future-growth/ 2026-03-20T14:48:11+00:00 https://www.pharmaglobenewswire.com/congestive-heart-failure-market-size-7mm-was-usd-6900-million-in-2023-and-it-is-expected-to-grow-by-2034-estimates-delveinsight/ 2026-03-20T14:46:02+00:00 https://www.pharmaglobenewswire.com/pigment-epithelial-detachment-market-expected-to-experience-substantial-expansion-across-7mm-propelled-by-growing-elderly-demographics-and-breakthrough-treatments-delveinsight/ 2026-03-20T07:44:12+00:00 https://www.pharmaglobenewswire.com/emerging-therapies-set-to-propel-the-trk-fusion-cancer-market-through-2032-delveinsight-report/ 2026-03-20T03:55:16+00:00 https://www.pharmaglobenewswire.com/delveinsights-trichotillomania-market-analysis-epidemiological-data-and-forecast-through-2032/ 2026-03-20T03:48:47+00:00 https://www.pharmaglobenewswire.com/transverse-myelitis-market-insights-report-2034-delveinsight/ 2026-03-20T03:39:21+00:00 https://www.pharmaglobenewswire.com/motor-neuron-disease-pipeline-insight-2026-driving-hope-through-next-generation-therapies/ 2026-03-19T19:30:57+00:00 https://www.pharmaglobenewswire.com/cutaneous-t-cell-lymphoma-market-growth-momentum-and-pipeline-advancements-through-2034-delveinsight/ 2026-03-19T19:27:05+00:00 https://www.pharmaglobenewswire.com/melanoma-market-2034-immunotherapy-breakthroughs-mrna-vaccines-and-future-oncology-trends/ 2026-03-19T19:24:45+00:00 https://www.pharmaglobenewswire.com/global-phototherapies-for-psoriasis-market-witnesses-robust-growth-driven-by-innovation-and-rising-disease-burden/ 2026-03-19T17:22:05+00:00 https://www.pharmaglobenewswire.com/progressive-fibrosing-interstitial-lung-disease-market-size-in-the-7mm-is-expected-to-grow-at-a-significant-cagr-by-2034-estimates-delveinsight/ 2026-03-19T13:22:14+00:00 https://www.pharmaglobenewswire.com/colorectal-cancer-market-size-7mm-was-usd-13000-million-in-2023-growing-5-cagr-to-2034-estimates-delveinsight/ 2026-03-19T13:02:54+00:00 https://www.pharmaglobenewswire.com/global-peanut-allergy-treatment-market-shows-rapid-expansion-toward-usd-2-4-billion-by-2034-amid-rising-prevalence-and-breakthrough-immunotherapy-innovations/ 2026-03-19T12:39:23+00:00 https://www.pharmaglobenewswire.com/peritoneal-carcinomatosis-market-forecast-2040-epidemiology-emerging-therapies-clinical-trials-key-companies-and-revenue-projections/ 2026-03-19T11:11:15+00:00 https://www.pharmaglobenewswire.com/sickle-cell-disease-market-set-for-robust-expansion-at-a-cagr-of-22-1-2026-2034-across-6mm-driven-by-rising-prevalence-and-breakthrough-gene-therapies-delveinsight/ 2026-03-19T11:11:04+00:00 https://www.pharmaglobenewswire.com/myelodysplastic-syndrome-clinical-trial-pipeline-gains-momentum-120-companies-lead-the-charge-in-pioneering-new-treatments-delveinsight/ 2026-03-13T05:25:52+00:00 https://www.pharmaglobenewswire.com/alk-inhibitor-clinical-trial-pipeline-gains-momentum-15-companies-lead-the-charge-in-pioneering-new-treatments-delveinsight/ 2026-03-13T05:15:11+00:00 https://www.pharmaglobenewswire.com/genital-warts-clinical-trial-pipeline-gains-momentum-30-companies-lead-the-charge-in-pioneering-new-treatments-delveinsight/ 2026-03-10T04:14:50+00:00 https://www.pharmaglobenewswire.com/herpes-labialis-clinical-trial-pipeline-appears-robust-with-6-key-pharma-companies-actively-working-in-the-domain-delveinsight/ 2026-03-10T04:02:04+00:00 https://www.pharmaglobenewswire.com/anti-cd38-antibody-treatment-pipeline-shows-strong-momentum-as-10-pharma-companies-in-the-race-delveinsight/ 2026-03-10T03:35:47+00:00 https://www.pharmaglobenewswire.com/shaping-the-future-of-memory-care-dementia-associated-with-alzheimers-disease-pipeline-insight-2025/ 2026-02-11T18:39:38+00:00 https://www.pharmaglobenewswire.com/obstructive-sleep-apnea-pipeline-insight-2025-unlocking-new-frontiers-in-therapeutic-innovation/ 2026-02-11T18:36:40+00:00 https://www.pharmaglobenewswire.com/endometrial-cancer-market-poised-for-significant-growth-through-2034-reports-delveinsight/ 2026-02-11T18:35:27+00:00 https://www.pharmaglobenewswire.com/waldenstrom-macroglobulinemia-market-set-for-robust-growth-through-2034-according-to-delveinsight/ 2026-02-11T18:31:22+00:00 https://www.pharmaglobenewswire.com/cannabinoid-agonists-pipeline-insight-2025-and-the-future-of-targeted-therapeutics/ 2026-02-11T04:06:34+00:00 https://www.pharmaglobenewswire.com/interleukin-2-il-2-inhibitor-pipeline-insight-2025-advancing-precision-immune-modulation/ 2026-02-11T04:03:51+00:00 https://www.pharmaglobenewswire.com/the-global-medical-device-cleaning-market-is-forecasted-to-achieve-6-75-cagr-by-2032-as-per-delveinsight/ 2026-02-10T14:12:13+00:00 https://www.pharmaglobenewswire.com/alzheimers-disease-market/ 2026-02-10T14:06:04+00:00 https://www.pharmaglobenewswire.com/paroxysmal-nocturnal-hemoglobinuria-market/ 2026-02-10T14:03:50+00:00 https://www.pharmaglobenewswire.com/tracheostomy-products-market-poised-for-robust-growth-expected-to-expand-at-4-cagr-through-2032-driven-by-increasing-global-demand-and-technological-innovation-delveinsight/ 2026-02-10T05:30:47+00:00 https://www.pharmaglobenewswire.com/4281-2/ 2026-02-10T05:21:49+00:00 https://www.pharmaglobenewswire.com/lyme-disease-market-size-in-the-7mm-is-estimated-to-grow-with-a-significant-cagr-by-2034-estimates-delveinsight/ 2026-02-10T04:43:00+00:00 https://www.pharmaglobenewswire.com/crispr-therapies-clinical-trial-pipeline-appears-robust-with-25-key-pharma-companies-actively-working-in-the-domain-delveinsight/ 2026-02-09T12:42:09+00:00 https://www.pharmaglobenewswire.com/atrial-fibrillation-treatment-pipeline-shows-strong-momentum-as-12-pharma-companies-in-the-race-delveinsight/ 2026-02-09T12:37:35+00:00 https://www.pharmaglobenewswire.com/shilpa-medicares-biologicals-unit-secures-fda-orphan-drug-designation/ 2026-02-09T07:31:15+00:00 https://www.pharmaglobenewswire.com/fda-grants-orphan-drug-designation-to-anti-cd7-car-t-therapy-for-rare-t-cell-leukemias-and-lymphomas/ 2026-02-09T07:10:04+00:00 https://www.pharmaglobenewswire.com/fda-grants-breakthrough-therapy-designation-to-bezuclastinib-plus-sutent-for-advanced-gist/ 2026-02-09T06:49:57+00:00 https://www.pharmaglobenewswire.com/fda-grants-fast-track-designation-to-lbl-034-for-rr-multiple-myeloma/ 2026-02-09T05:56:02+00:00 https://www.pharmaglobenewswire.com/quetzal-therapeutics-qtx-2101-secures-fda-fast-track-designation-for-the-treatment-of-acute-promyelocytic-leukemia/ 2026-02-09T05:38:24+00:00 https://www.pharmaglobenewswire.com/biogens-litifilimab-receives-fda-breakthrough-therapy-designation-for-cutaneous-lupus-erythematosus/ 2026-02-09T05:32:52+00:00 https://www.pharmaglobenewswire.com/fda-grants-ipsens-ipn60340-breakthrough-therapy-designation-for-acute-myeloid-leukemia/ 2026-02-09T05:24:40+00:00 https://www.pharmaglobenewswire.com/basal-cell-neoplasms-clinical-trial-pipeline-appears-robust-with-25-key-pharma-companies-actively-working-in-the-domain-delveinsight/ 2026-02-05T10:45:35+00:00 https://www.pharmaglobenewswire.com/tgf-beta-inhibitors-treatment-pipeline-shows-strong-momentum-as-10-pharma-companies-in-the-race-delveinsight/ 2026-02-05T10:31:46+00:00 https://www.pharmaglobenewswire.com/bipolar-disorder-clinical-trial-pipeline-expands-as-20-companies-driving-innovation-in-the-therapeutics-delveinsight/ 2026-02-05T10:19:17+00:00 https://www.pharmaglobenewswire.com/advanced-liver-cancer-clinical-trial-pipeline-shows-potential-with-active-contributions-from-50-key-companies-delveinsight/ 2026-02-05T10:06:57+00:00 https://www.pharmaglobenewswire.com/peanut-allergy-clinical-trial-pipeline-accelerates-as-12-pharma-companies-rigorously-develop-drugs-for-market-entry-delveinsight/ 2026-02-05T09:50:06+00:00 https://www.pharmaglobenewswire.com/bispecific-antibody-pipeline-drugs-and-companies-insight-report-2025-clinical-commercial-and-developmental-analysis/ 2026-02-04T11:21:04+00:00 https://www.pharmaglobenewswire.com/complicated-urinary-tract-infection-market/ 2026-02-04T11:15:00+00:00 https://www.pharmaglobenewswire.com/clinical-trial-support-services-market-insights/ 2026-02-04T11:11:46+00:00 https://www.pharmaglobenewswire.com/invasive-aspergillosis-market-outlook-signals-sustained-growth-to-2034/ 2026-02-04T11:07:27+00:00 https://www.pharmaglobenewswire.com/global-medical-drones-market-poised-to-expand-at-17-34-cagr-through-2032-says-delveinsight/ 2026-02-04T11:05:22+00:00 https://www.pharmaglobenewswire.com/autism-spectrum-disorder-pipeline-insight-2025-emerging-therapies-clinical-trial-updates-and-regulatory-progress/ 2026-02-04T11:02:57+00:00 https://www.pharmaglobenewswire.com/global-colorectal-surgical-devices-market-expected-to-grow-at-a-steady-cagr-of-8-through-2032-delveinsight/ 2026-02-03T10:14:30+00:00 https://www.pharmaglobenewswire.com/pde4b-inhibitors-market-size-poised-for-strong-growth-through-2034-driven-by-innovative-therapies-and-clinical-advancements-delveinsight/ 2026-02-03T10:04:24+00:00 https://www.pharmaglobenewswire.com/myelofibrosis-market-size-is-projected-to-grow-at-a-cagr-of-9-00-by-2034-estimates-delveinsight/ 2026-02-03T09:03:24+00:00 https://www.pharmaglobenewswire.com/chronic-gout-market-size-poised-for-strong-growth-through-2034-driven-by-innovative-therapies-and-clinical-advancements-delveinsight/ 2026-02-03T08:42:41+00:00 https://www.pharmaglobenewswire.com/bone-marrow-failure-market-size-poised-for-strong-growth-through-2034-driven-by-innovative-therapies-and-clinical-advancements-delveinsight/ 2026-02-03T08:25:21+00:00 https://www.pharmaglobenewswire.com/hodgkins-lymphoma-market-poised-for-strong-growth-through-2034-driven-by-innovative-therapies-and-clinical-advancements-delveinsight/ 2026-02-03T08:05:45+00:00 https://www.pharmaglobenewswire.com/pharmaceuticals-market-size-is-estimated-to-grow-at-a-cagr-of-6-54-estimates-delveinsight/ 2026-02-03T07:16:25+00:00 https://www.pharmaglobenewswire.com/mobile-clinics-market-size-is-estimated-to-grow-at-a-cagr-of-5-99-estimates-delveinsight/ 2026-02-03T06:17:51+00:00 https://www.pharmaglobenewswire.com/antisense-oligonucleotide-therapeutics-treatment-pipeline-shows-strong-momentum-as-70-pharma-companies-in-the-race-delveinsight/ 2026-02-02T16:01:37+00:00 https://www.pharmaglobenewswire.com/untreated-metastatic-or-unresectable-melanoma-clinical-trial-pipeline-expands-as-10-companies-driving-innovation-in-the-therapeutics-delveinsight/ 2026-02-02T15:55:34+00:00 https://www.pharmaglobenewswire.com/fda-launches-precheck-pilot-program/ 2026-02-02T11:37:16+00:00 https://www.pharmaglobenewswire.com/novartis-ianalumab-receives-fda-breakthrough-therapy-designation-sjogrens-disease/ 2026-02-02T11:28:25+00:00 https://www.pharmaglobenewswire.com/encoded-therapeutics-achieves-breakthrough-status-for-etx101-for-dravet-syndrome/ 2026-02-02T11:07:09+00:00 https://www.pharmaglobenewswire.com/pneumococcal-infections-clinical-trial-pipeline-expands-as-15-companies-driving-innovation-in-the-therapeutics-delveinsight/ 2026-01-29T13:48:09+00:00 https://www.pharmaglobenewswire.com/non-cystic-fibrosis-bronchiectasis-market-size-is-projected-to-grow-at-a-cagr-of-16-25-by-2034-estimates-delveinsight/ 2026-01-29T13:10:23+00:00 https://www.pharmaglobenewswire.com/bioanalytical-testing-services-market-size-expected-to-witness-significant-expansion-at-16-cagr-by-2032-delveinsight/ 2026-01-29T12:22:47+00:00 https://www.pharmaglobenewswire.com/big-data-in-healthcare-market-size-is-estimated-to-grow-at-a-cagr-of-20-11-estimates-delveinsight/ 2026-01-29T11:49:43+00:00 https://www.pharmaglobenewswire.com/thyroid-gland-disorder-treatment-market-set-for-explosive-growth-expected-to-register-3-26-cagr-by-2032-delveinsight/ 2026-01-29T11:29:10+00:00 https://www.pharmaglobenewswire.com/digital-twins-in-healthcare-market-set-for-explosive-growth-expected-to-register-28-cagr-by-2032-delveinsight/ 2026-01-29T10:08:23+00:00 https://www.pharmaglobenewswire.com/merkel-cell-carcinoma-market-size-in-the-7mm-is-projected-to-grow-by-2034-estimates-delveinsight/ 2026-01-29T09:22:41+00:00 https://www.pharmaglobenewswire.com/pd-l1-inhibitors-market-size-in-the-7mm-was-usd-36-billion-in-2023-and-it-is-projected-to-grow-by-2034-estimates-delveinsight/ 2026-01-29T08:49:16+00:00 https://www.pharmaglobenewswire.com/focal-segmental-glomerulosclerosis-market-size-7mm-was-usd-734-million-in-2022-and-it-is-projected-to-grow-by-2034-estimated-delveinsight/ 2026-01-29T08:42:07+00:00 https://www.pharmaglobenewswire.com/vitiligo-clinical-trial-pipeline-gains-momentum-20-companies-lead-the-charge-in-pioneering-new-treatments-delveinsight/ 2026-01-29T08:23:38+00:00 https://www.pharmaglobenewswire.com/dermatomyositis-market-poised-for-strong-growth-through-2034-reports-delveinsight/ 2026-01-22T11:19:09+00:00 https://www.pharmaglobenewswire.com/multiple-sclerosis-pipeline-2025-clinical-progress-moa-roa-and-regulatory-advances/ 2026-01-22T11:16:03+00:00 https://www.pharmaglobenewswire.com/cannabinoid-clinical-trial-pipeline-appears-robust-with-40-key-pharma-companies-actively-working-in-the-domain-delveinsight/ 2026-01-22T10:08:05+00:00 https://www.pharmaglobenewswire.com/ph-ild-market-size-in-the-7mm-was-usd-3-billion-in-2024-and-is-projected-to-increase-by-2034-estimates-delveinsight/ 2026-01-22T09:39:53+00:00 https://www.pharmaglobenewswire.com/structural-heart-devices-market-poised-for-significant-growth-projected-to-reach-usd-25-billion-by-2032-driven-by-increasing-adoption-of-minimally-invasive-therapies-delveinsight/ 2026-01-22T09:17:17+00:00 https://www.pharmaglobenewswire.com/global-embolic-protection-devices-market-poised-for-robust-expansion-projected-to-grow-at-a-cagr-of-8-through-2032-delveinsight/ 2026-01-22T09:05:15+00:00 https://www.pharmaglobenewswire.com/erectile-dysfunction-devices-market-poised-for-robust-growth-expected-to-expand-at-8-cagr-through-2032-driven-by-increasing-global-demand-and-technological-innovation-delveinsight/ 2026-01-22T08:15:42+00:00 https://www.pharmaglobenewswire.com/atossa-therapeutics-z-endoxifen-achieves-fda-orphan-drug-designation-for-duchenne-muscular-dystrophy/ 2026-01-21T14:03:30+00:00 https://www.pharmaglobenewswire.com/btk-inhibitors-pipeline-therapies/ 2026-01-21T11:32:01+00:00 https://www.pharmaglobenewswire.com/urea-cycle-disorders-market-poised-for-strong-expansion-by-2034-highlights-delveinsight/ 2026-01-21T11:09:45+00:00 https://www.pharmaglobenewswire.com/global-protein-expression-market-size-is-poised-to-hit-usd-6491-18-million-by-2032/ 2026-01-21T11:01:03+00:00 https://www.pharmaglobenewswire.com/eli-lillys-sofetabart-mipitecan-receives-fda-breakthrough-therapy-designation-for-platinum-resistant-ovarian-cancer/ 2026-01-21T10:37:58+00:00 https://www.pharmaglobenewswire.com/lantern-pharmas-lp-284-achieves-third-fda-orphan-drug-designation-for-soft-tissue-sarcomas/ 2026-01-21T07:23:27+00:00 https://www.pharmaglobenewswire.com/corvus-pharmaceuticals-reports-robust-data-for-soquelitinib-in-atopic-dermatitis/ 2026-01-21T06:30:52+00:00 https://www.pharmaglobenewswire.com/gsks-bepirovirsen-demonstrates-statistically-significant-functional-cure-rates-in-chronic-hepatitis-b/ 2026-01-21T06:02:21+00:00